Briley P A, Kouyoumdjian J C, Haidamous M, Gonnard P
Eur J Pharmacol. 1979 Feb 15;54(1-2):181-4. doi: 10.1016/0014-2999(79)90422-9.
L-glutamate and kainate administered intracerebroventricularly (i.c.v.) both produced dose-dependent increases in rat cerebellar cGMP. The increased cGMP produced by L-glutamate, but not that produced by kainate, could be completely abolished by the glutamate antagonist glutamate diethylester which had no effect alone. The data suggest that L-glutamate and kainate may be acting upon different sub-populations of glutamate receptors, both of which may be involved in the regulation of cerebellar cGMP levels.
